Switch to optionsXpress for advanced derivatives trading & earn 50 commission-free trades.
SureTrader Stock Hero Advertisement SPDR Advertisement
Home > Boards > US OTC > Medical - Drugs >

Cellceutix Corporation (CTIX)

Add CTIX Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator BigKahuna, BooDog, KarinCA, noretreat, TOB, starbuxsux
Search This Board:
Last Post: 3/30/2015 11:10:53 PM - Followers: 575 - Board type: Free - Posts Today: 125

Cellceutix Corporation (CTIX) 



Company Address:
100 Cumming Center, Suite 151-B
Beverly, MA 01915
Phone: 978-236-8717
Fax:  978-921-6564
Email:  info@cellceutix.com
CIK:  0001355250
Cellceutix is a publicly traded company under the symbol “CTIX”. Cellceutix is a clinical stage biopharmaceutical company developing innovative therapies in oncology, dermatology and antibiotic applications. Cellceutix believes it has a world-class portfolio of compounds and is now engaged in advancing its compounds and seeking strategic partnerships. Cellceutix’s anti-cancer drug Kevetrin is currently in a Phase 1 clinical trial at Harvard Cancer Centers’ Dana Farber Cancer Institute and Beth Israel Deaconess Medical Center. In the laboratory Kevetrin has shown to induce activation of p53, often referred to as the “Guardian Angel Gene” due to its crucial role in controlling cell mutations. Cellceutix is planning a Phase 2 clinical trial with its novel compound Brilacidin-OM for the prevention and treatment of Oral Mucositis. Brilacidin-OM, a defensin mimetic compound, has shown in the laboratory to reduce the occurrence of severe ulcerative oral mucositis by more than 94% compared to placebo. Cellceutix’s anti-psoriasis drug Prurisol is presently in a bioequivalence crossover clinical trial in Miami, FL. Prurisol is a small molecule that acts through immune modulation and PRINS reduction. Cellceutix’s key antibiotic, Brilacidin, is in a Phase 2b trial for Acute Bacterial Skin and Skin Structure Infections, or ABSSSI. Brilacidin has the potential to be a single-dose therapy or a dosing regimen that is shorter than currently marketed antibiotics for multi-drug resistant bacteria (Superbugs). Cellceutix has formed research collaborations with world-renowned research institutions in the United States and Europe, including MD Anderson Cancer Center, Beth Israel Deaconess Medical Center, and the University of Bologna.


Management:   http://cellceutix.com/team/
The above link is kept updated.

Ongoing Human Trials:  http://clinicaltrials.gov/ct2/results?term=Cellceutix+Pharmaceuticals&Search=Search
Product Pipeline:  http://cellceutix.com/pipeline/

Recent News and Press Releases: 

Seeking Alpha focus articles on CTIX: http://seekingalpha.com/symbol/CTIX
SEC Filings:  http://www.sec.gov/cgi-bin/browse-edgar?company=Cellceutix+Corp&match=&CIK=ctix&filenum=&State=&Country=&SIC=&owner=exclude&Find=Find+Companies&action=getcompany

Transfer Agent:
West Coast Stock Transfer, Inc.
721 N. Vulcan Ave. Ste. 205
Encinitas, CA 92024
(619) 664-4780 p
(760) 452-4423 f

Share Structure:  See SEC filing link above for current share structure

Cellceutix IP - Patent Filings:


Publication number US8338454 B2
Publication type Grant
Application number US 12/780,132
Publication date Dec 25, 2012
Filing date May 14, 2010
Priority date May 20, 2009
Also published as CA2762427A1, CN102438612A, EP2432464A2, US20100298374, US20130245062, WO2010135170A2, WO2010135170A3, Less «6 More »
Publication number 12780132, 780132, US 8338454 B2, US 8338454B2, US-B2-8338454, US8338454 B2, US8338454B2
Inventors Krishna Menon
Original Assignee Cellceutix Corporation
Export Citation BiBTeX, EndNote, RefMan
Patent Citations (6), Non-Patent Citations (41), Referenced by (1), Classifications (42)
External Links: USPTO, USPTO Assignment, Espacenet



Investor Relations:  info@cellceutix.com

Following is a WEEKLY chart:


All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.
Also, keep in mind that moderators may or may not have a position in said stock.  Being a moderator isn’t a sign of endorsement.
Please keep your posts on topic because your message(s) will probably be deleted when:
* Posting content that's off-topic to the subject of this board;
* Posting statements that don't add value to the discussion; or
* When you violate any other posting term of the iHub User Agreement: http://investorshub.advfn.com/boards/complex_terms.asp

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
CTIX News: Independent Research Initiates Analyst Coverage on Inventergy Global, Inc. (NASDAQ: INVT) with $1.20 Price Target 03/12/2015 08:00:00 AM
CTIX News: Quarterly Report (10-q) 02/09/2015 12:38:38 PM
CTIX News: Amended Statement of Ownership (sc 13g/a) 02/05/2015 05:24:25 PM
CTIX News: Special "Tech Boom" Profile and 4 Companies That May Take Investors for a Growth Ride 01/21/2015 07:00:00 AM
#95145  Sticky Note $CTIX Lead drug info, News, SEC filings, FDA KarinCA 03/21/15 12:39:45 PM
#93207  Sticky Note Tremendous follow through overall. KarinCA 03/02/15 03:58:13 PM
#92697  Sticky Note upcoming catalysts slcimmuno 02/26/15 09:18:08 AM
#90993  Sticky Note An Interview with Cellceutix CEO Leo Ehrlich BigKahuna 02/09/15 03:56:33 PM
#87958  Sticky Note Cellceutix Reports Spleen Lesion 'Disappears' in Patient With starbuxsux 01/20/15 08:25:55 AM
#74575  Sticky Note Cellceutix Announces Positive Top-Line Data From Phase 2b TOB 10/23/14 11:59:10 AM
#96275   Exhausted bearish sentiment with the ugliest rounding bottom etradeedge 03/30/15 11:10:53 PM
#96273   None of us can answer that without wild KarinCA 03/30/15 10:15:56 PM
#96272   It was stated, middle of April for cohorts daydreaming2 03/30/15 09:37:25 PM
#96271   Thanks for sharing Wild, I look forward to Matagordaville 03/30/15 09:34:50 PM
#96270   Right after the start of the B-OM trial. TheHound 03/30/15 09:23:31 PM
#96269   When can we expect the DF Paper? tombrady12nh 03/30/15 09:22:48 PM
#96268   Damn!!! Go CTIX tombrady12nh 03/30/15 09:22:11 PM
#96267   I thought the same thing when I saw TheDane 03/30/15 09:07:38 PM
#96266   Just wanted to mention that there is a NOTPERFECT 03/30/15 08:56:54 PM
#96265   Only one drug but worth $2.2B, wow. lousy engineer 03/30/15 08:48:03 PM
#96264   Maybe in 3 years we will be like Aspx BobbyKIrk 03/30/15 08:28:32 PM
#96263   Tomorrow is still march...so maybe day after tomorrow. scottsmith 03/30/15 08:04:58 PM
#96262   Lol. MrW 03/30/15 08:00:17 PM
#96261   OK, so tomorrow we begin the journey and havendale 03/30/15 07:59:43 PM
#96260   Apparently he can do anything he wants and TheDane 03/30/15 07:44:15 PM
#96259   Thanks for the reply incubus -- i can't scottsmith 03/30/15 07:27:39 PM
#96258   BARDA How BARDA Is Helping Speed Up Drug Development/Manufacture http://www.lif slcimmuno 03/30/15 07:02:11 PM
#96257   "That was an incoherent post" eventhelosers 03/30/15 05:57:42 PM
#96256   That was an incoherent post. All this scottsmith 03/30/15 05:48:48 PM
#96255   Nope but it all sounds very "glass half eventhelosers 03/30/15 05:43:58 PM
#96254   He will when he here's back, and he eventhelosers 03/30/15 05:41:19 PM
#96253   Could Obama buy Brilacidon? Maybe the government scottsmith 03/30/15 05:38:48 PM
#96252   " The realistic view is that K needs eventhelosers 03/30/15 05:26:15 PM
#96251   right. that is the "half-full" view. noretreat 03/30/15 05:03:03 PM
#96250   Eggsactly eventhelosers 03/30/15 04:52:14 PM
#96249   That's precious eventhelosers 03/30/15 04:49:56 PM
#96248   Boooo whoooo eventhelosers 03/30/15 04:47:33 PM
#96247   Like nice find Scoob, now if we just Cassius Longinus 03/30/15 04:36:21 PM
#96244   Ruh Roh... ericseb2003 03/30/15 04:30:05 PM
#96243   I agree, Nerby. Doesn't sound like someone whose dougwur 03/30/15 04:29:14 PM
#96242   Picked up some today tombrady12nh 03/30/15 04:17:05 PM
#96241   Wild...what did you ask Leo? TheDane 03/30/15 04:12:30 PM
#96240   Not quite yet. Tomorrow perhaps. TheHound 03/30/15 04:08:59 PM
#96239   I've been saying that for years now ;-) TheHound 03/30/15 04:08:32 PM
#96238   Wild thanks for posting this. The story continues 58nout 03/30/15 04:07:15 PM
#96237   I think we finally get approval for NASDAQ havendale 03/30/15 04:03:21 PM
#96236   Agreed wildthing, in other words and Leo speak havendale 03/30/15 03:52:40 PM
#96235   Thanks for answering - sure wish Bologna would djs7 03/30/15 03:50:02 PM
#96234   Current share price is actually up a penny TOB 03/30/15 03:33:49 PM
#96232   Bottom is in feeders, time to start feeding. eventhelosers 03/30/15 03:06:24 PM
#96231   Good enough for me. Thanks. scottsmith 03/30/15 02:46:00 PM
#96230   Not possible to test two dosage amounts in parallel? BigKahuna 03/30/15 02:44:56 PM
#96229   I'm not going to post the questions but wild4ctix 03/30/15 02:40:21 PM
#96228   What tough questions were asked? He never replies grizzlyman 03/30/15 02:24:41 PM
#96227   Interesting BK. Anyone else here see this in frrol 03/30/15 02:17:49 PM
#96226   Maybe you can post your questions? Thanks. scottsmith 03/30/15 02:06:21 PM
#96225   I'm mostly a " half full " kinda wild4ctix 03/30/15 02:04:52 PM
#96224   Hi Bigkahuna, djs7 03/30/15 02:03:42 PM
#96223   The "half-empty" view is more like..."If K were BigKahuna 03/30/15 01:03:06 PM
#96222   Nerby I have the same reaction to her frrol 03/30/15 12:57:46 PM